Cbl-b-IN-2
Cbl-b-IN-2 (Example 8) is an orally bioavailable compound, can inhibit the E3 enzyme Casitas B-lineage lymphoma proto-oncogene-b (Cbl-b) in the ubiquitin proteasome pathway. Cbl-b-IN-2 can be used to modulate the immune system and diseases amenable to immune system modulation. Cbl-b-IN-2 (Example 8) also may be administered to an individual with cancer, either alone or as part of a combination, with one or more of an immune checkpoint inhibitor, an anti-neoplastic agent, and radiation agent[1].
Product Specifications
CAS Number
2503325-21-9
UNSPSC
12352005
Target
E1/E2/E3 Enzyme
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
COVID-19-immunoregulation
Field of Research
Cancer; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/cbl-b-in-2.html
Purity
98.65
Solubility
DMSO : 140 mg/mL (ultrasonic)
Smiles
O=C1N(C2=CC=CC(C3(CC4=NN=CN4C)COC3)=C2)CC5=C1C=C(CN6C[C@@H](C)C(F)(F)CC6)C=C5C(F)(F)F
Molecular Formula
C29H30F5N5O2
Molecular Weight
575.57
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
ROR2 (ROR2/1912), CF488A conjugate, 0.1mg/mL
Selenophosphate synthetase 1 (SEPHS1) (NM_001195604) Human Over-expression Lysate
![Staufen (STAU1) Mouse Monoclonal Antibody [Clone ID: OTI6C11]](https://cdn.genprice.uk/products/937/68dd18bb061270361e908b9e/imageurl/cf811484.webp)
Staufen (STAU1) Mouse Monoclonal Antibody [Clone ID: OTI6C11]
